Cypherpunk Technologies Inc. $CYPH
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Fiscal year end
- December 31
- Shares outstanding
- 107,764,382 [10-Q 2026-08-12]
What the company doesAI summary of filing
Cypherpunk Technologies Inc. operates two primary business segments. First, it is a privacy technology company implementing a digital asset treasury strategy focused on acquiring and holding Zcash (ZEC), a privacy-focused cryptocurrency, with the stated objective of accumulating at least 5% of circulating ZEC supply over time. Second, through its subsidiary Leap Therapeutics, the company develops biomarker-targeted antibody therapies for cancer treatment, with its lead program sirexatamab (DKN-01) currently in clinical development for colorectal cancer and a preclinical program FL-501 targeting GDF-15 for cachexia-related indications. The company is clinical-stage with respect to its drug development operations and pre-revenue as to commercial sales, having raised $58.88 million in October 2025 to fund its digital asset strategy and ongoing operations. [10-K 2026-03-16]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$37.78M | −$6.12M | $7.62M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | — | $5.00M | −$43.90M | $14.04M | [DEF 14A 2026-04-29] |
| FY ended Dec 2024 | — | −$68.00M | −$60.30M | $47.25M | [DEF 14A 2026-04-29] |
- Quarterly cash burn
- −$3.06M
- Cash runway Estimate
- ~7.5 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-08 | 38,317,897 | [10-Q 2024-11-13] |
| 2025-03-20 | 41,257,602 | [10-K 2025-03-26] |
| 2025-05-09 | 41,439,529 | [10-Q 2025-05-13] |
| 2025-08-11 | 41,439,529 | [10-Q 2025-08-14] |
| 2025-11-10 | 56,651,840 | [10-Q 2025-11-12] |
| 2026-03-11 | 89,979,619 | [10-K 2026-03-16] |
| 2026-05-12 | 106,464,482 | [10-Q 2026-05-14] |
| 2026-08-10 | 107,764,382 | [10-Q 2026-08-12] |
- Shelf registration
- S-3 filed 2024-05-10; declared effective 2024-05-23 [S-3 2024-05-10]
Listing status
Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-21. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-21] |
| 2026-03-09 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-03-09] |
| 2025-09-11 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-09-11] |
| 2025-03-17 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-03-17] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-25 | Oei Khing Djien | sell | 168,750 | $3.92 | [4 2026-09-25] |
| 2026-09-23 | Martin Patricia A. | sell | 50,000 | $3.86 | [4 2026-09-25] |
| 2026-08-26 | Dietz Thomas John | sell | 20,000 | $1.72 | [4 2026-08-27] |
| 2026-08-17 | Mcevoy William Patrick Iii | other | 16,570,852 | $0.00 | [4 2026-08-19] |
| 2026-08-17 | Winklevoss Capital Fund, Llc | other | 16,570,852 | $0.00 | [4 2026-08-19] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-22 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-09-02 | 8-K | Other events |
| 2026-08-19 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-08-18 | 8-K | Material agreement entered; Unregistered sale of equity; Other events |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-08-12 | 8-K | Results of operations; Other events |
| 2026-07-21 | 8-K | Listing notice or transfer |
| 2026-06-22 | 8-K | Shareholder vote results |
| 2026-05-26 | 8-K | Other events |
| 2026-05-14 | 8-K | Results of operations |
| 2026-05-14 | 10-Q | Quarterly report |
| 2026-04-29 | DEF 14A | Proxy statement |
Alerts for $CYPH
Email me when Cypherpunk Technologies Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.